President Donald Trump suspended the green card lottery program on Thursday, which allowed the suspect in the Brown University and MIT shootings to come to the United States. Homeland Security ...
Inhibrx has recruited 46 of the 60 patients in the randomized Phase 2 portion of the Phase 2/3 clinical trial evaluating INBRX-106 in combination with Keytruda versus Keytruda as a first-line ...
SAN DIEGO, Dec. 16, 2025 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback